vs
Side-by-side financial comparison of Huntington Ingalls Industries (HII) and Incyte (INCY). Click either name above to swap in a different company.
Huntington Ingalls Industries is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Incyte). Incyte runs the higher net margin — 23.8% vs 8.9%, a 14.9% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 13.8%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs -25.2%).
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
HII vs INCY — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.3B |
| Net Profit | $149.0M | $303.3M |
| Gross Margin | — | — |
| Operating Margin | 9.3% | 23.7% |
| Net Margin | 8.9% | 23.8% |
| Revenue YoY | 13.8% | 20.9% |
| Net Profit YoY | — | 91.7% |
| EPS (diluted) | $3.79 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.7B | $1.3B | ||
| Q4 25 | $3.5B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.1B | $1.2B | ||
| Q1 25 | $2.7B | $1.1B | ||
| Q4 24 | $3.0B | $1.2B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $3.0B | $1.0B |
| Q1 26 | $149.0M | $303.3M | ||
| Q4 25 | $159.0M | $299.3M | ||
| Q3 25 | $145.0M | $424.2M | ||
| Q2 25 | $152.0M | $405.0M | ||
| Q1 25 | $149.0M | $158.2M | ||
| Q4 24 | $123.0M | $201.2M | ||
| Q3 24 | $101.0M | $106.5M | ||
| Q2 24 | $173.0M | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 92.0% | ||
| Q3 25 | — | 92.8% | ||
| Q2 25 | — | 93.5% | ||
| Q1 25 | — | 93.0% | ||
| Q4 24 | — | 92.5% | ||
| Q3 24 | — | 92.4% | ||
| Q2 24 | — | 92.7% |
| Q1 26 | 9.3% | 23.7% | ||
| Q4 25 | 4.9% | 22.3% | ||
| Q3 25 | 5.0% | 32.5% | ||
| Q2 25 | 5.3% | 43.6% | ||
| Q1 25 | 5.9% | 19.5% | ||
| Q4 24 | 3.7% | 25.6% | ||
| Q3 24 | 3.0% | 12.8% | ||
| Q2 24 | 6.3% | -45.8% |
| Q1 26 | 8.9% | 23.8% | ||
| Q4 25 | 4.6% | 19.9% | ||
| Q3 25 | 4.5% | 31.1% | ||
| Q2 25 | 4.9% | 33.3% | ||
| Q1 25 | 5.4% | 15.0% | ||
| Q4 24 | 4.1% | 17.1% | ||
| Q3 24 | 3.7% | 9.4% | ||
| Q2 24 | 5.8% | -42.6% |
| Q1 26 | $3.79 | $1.47 | ||
| Q4 25 | $4.06 | $1.46 | ||
| Q3 25 | $3.68 | $2.11 | ||
| Q2 25 | $3.86 | $2.04 | ||
| Q1 25 | $3.79 | $0.80 | ||
| Q4 24 | $3.15 | $0.90 | ||
| Q3 24 | $2.56 | $0.54 | ||
| Q2 24 | $4.38 | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $216.0M | — |
| Total DebtLower is stronger | $2.7B | — |
| Stockholders' EquityBook value | $5.1B | $5.6B |
| Total Assets | $12.5B | $7.3B |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $216.0M | — | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $987.3M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $5.1B | $5.6B | ||
| Q4 25 | $5.1B | $5.2B | ||
| Q3 25 | $5.0B | $4.7B | ||
| Q2 25 | $4.9B | $4.2B | ||
| Q1 25 | $4.8B | $3.7B | ||
| Q4 24 | $4.7B | $3.4B | ||
| Q3 24 | $4.2B | $3.2B | ||
| Q2 24 | $4.2B | $3.0B |
| Q1 26 | $12.5B | $7.3B | ||
| Q4 25 | $12.7B | $7.0B | ||
| Q3 25 | $12.3B | $6.3B | ||
| Q2 25 | $12.1B | $5.8B | ||
| Q1 25 | $12.1B | $5.7B | ||
| Q4 24 | $12.1B | $5.4B | ||
| Q3 24 | $11.1B | $5.0B | ||
| Q2 24 | $11.3B | $4.7B |
| Q1 26 | 0.52× | — | ||
| Q4 25 | 0.53× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-390.0M | — |
| Free Cash FlowOCF − Capex | $-461.0M | — |
| FCF MarginFCF / Revenue | -27.7% | — |
| Capex IntensityCapex / Revenue | 4.4% | — |
| Cash ConversionOCF / Net Profit | -2.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $795.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-390.0M | — | ||
| Q4 25 | $650.0M | $543.3M | ||
| Q3 25 | $118.0M | $559.4M | ||
| Q2 25 | $823.0M | $44.7M | ||
| Q1 25 | $-395.0M | $266.1M | ||
| Q4 24 | $391.0M | $381.2M | ||
| Q3 24 | $213.0M | $310.9M | ||
| Q2 24 | $-9.0M | $-575.6M |
| Q1 26 | $-461.0M | — | ||
| Q4 25 | $516.0M | — | ||
| Q3 25 | $13.0M | — | ||
| Q2 25 | $727.0M | — | ||
| Q1 25 | $-462.0M | — | ||
| Q4 24 | $277.0M | — | ||
| Q3 24 | $125.0M | — | ||
| Q2 24 | $-99.0M | — |
| Q1 26 | -27.7% | — | ||
| Q4 25 | 14.8% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 23.6% | — | ||
| Q1 25 | -16.9% | — | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | -3.3% | — |
| Q1 26 | 4.4% | — | ||
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.0% | — |
| Q1 26 | -2.62× | — | ||
| Q4 25 | 4.09× | 1.82× | ||
| Q3 25 | 0.81× | 1.32× | ||
| Q2 25 | 5.41× | 0.11× | ||
| Q1 25 | -2.65× | 1.68× | ||
| Q4 24 | 3.18× | 1.89× | ||
| Q3 24 | 2.11× | 2.92× | ||
| Q2 24 | -0.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
